| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophysical Journal 73: 2446-2455 (1997)
© 1997 the Biophysical Society
Department of Anesthesia, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
ABSTRACT
When nicotinic acetylcholine receptors are reconstituted into lipid bilayers lacking cholesterol, agonists no longer stimulate cation flux. The kinetics of this process are difficult to study because variations in vesicle morphology cause errors in flux measurements. We developed a new stopped-flow fluorescence assay to study activation independently of vesicle morphology. When receptors were rapidly mixed with agonist plus ethidium, the earliest fluorescence increase reported the fraction of channels that opened and their apparent rate of fast desensitization. These processes were absent when the receptor was reconstituted into dioleoylphosphatidylcholine or into a mixture of that lipid with dioleoylphosphatidic acid (12 mol%), even though a fluorescent agonist reported that resting-state receptors were still present. The agonist-induced channel opening probability increased with bilayer cholesterol, with a midpoint value of 9 +/- 1.7 mol% and a Hill coefficient of 1.9 +/- 0.69, reaching a plateau above 20-30 mol% cholesterol that was equal to the native value. On the other hand, the observed fast desensitization rate was comparable to that for native membranes from the lowest cholesterol concentration examined (5 mol%). Thus the ability to reach the open state after activation varies with the cholesterol concentration in the bilayer, whereas the rate of the open state to fast desensitized state transition is unaffected. The structural basis for this is unknown, but an interesting corollary is that the channels of newly synthesized receptors are not fully primed by cholesterol until they are inserted into the plasma membrane--a novel form of posttranslational processing.
This article has been cited by other articles:
 |
|
 |
|
  S. Mennerick, M. Lamberta, H.-J. Shu, J. Hogins, C. Wang, D. F. Covey, L. N. Eisenman, and C. F. Zorumski Effects on Membrane Capacitance of Steroids with Antagonist Properties at GABAA Receptors Biophys. J., July 1, 2008; 95(1): 176 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Baenziger, S. E. Ryan, M. M. Goodreid, N. Q. Vuong, R. M. Sturgeon, and C. J. B. daCosta Lipid Composition Alters Drug Action at the Nicotinic Acetylcholine Receptor Mol. Pharmacol., March 1, 2008; 73(3): 880 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Shaikh, A. C. Dumaual, A. Castillo, D. LoCascio, R. A. Siddiqui, W. Stillwell, and S. R. Wassall Oleic and Docosahexaenoic Acid Differentially Phase Separate from Lipid Raft Molecules: A Comparative NMR, DSC, AFM, and Detergent Extraction Study Biophys. J., September 1, 2004; 87(3): 1752 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cascio Structure and Function of the Glycine Receptor and Related Nicotinicoid Receptors J. Biol. Chem., May 7, 2004; 279(19): 19383 - 19386. [Full Text] [PDF]
|
|
|
|
|
|
C. J. B. daCosta, I. D. Wagg, M. E. McKay, and J. E. Baenziger Phosphatidic Acid and Phosphatidylserine Have Distinct Structural and Functional Interactions with the Nicotinic Acetylcholine Receptor J. Biol. Chem., April 9, 2004; 279(15): 14967 - 14974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. M. de Almeida, L. M. S. Loura, M. Prieto, A. Watts, A. Fedorov, and F. J. Barrantes Cholesterol Modulates the Organization of the {gamma}M4 Transmembrane Domain of the Muscle Nicotinic Acetylcholine Receptor Biophys. J., April 1, 2004; 86(4): 2261 - 2272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Miller The nature of sites of general anaesthetic action Br. J. Anaesth., July 1, 2002; 89(1): 17 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Trudell and E. Bertaccini Molecular modelling of specific and non-specific anaesthetic interactions Br. J. Anaesth., July 1, 2002; 89(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. B. daCosta, A. A. Ogrel, E. A. McCardy, M. P. Blanton, and J. E. Baenziger Lipid-Protein Interactions at the Nicotinic Acetylcholine Receptor. A FUNCTIONAL COUPLING BETWEEN NICOTINIC RECEPTORS AND PHOSPHATIDIC ACID-CONTAINING LIPID BILAYERS J. Biol. Chem., January 4, 2002; 277(1): 201 - 208. [Abstract] [Full Text]
|
|
|
|
|
|
J. Santiago, G. R. Guzman, L. V. Rojas, R. Marti, G. A. Asmar-Rovira, L. F. Santana, M. McNamee, and J. A. Lasalde-Dominicci Probing the Effects of Membrane Cholesterol in the Torpedo californica Acetylcholine Receptor and the Novel Lipid-exposed Mutation alpha C418W in Xenopus Oocytes J. Biol. Chem., November 30, 2001; 276(49): 46523 - 46532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Walcher, J. Altschuh, and H. Sandermann Jr. The Lipid/Protein Interface as Xenobiotic Target Site. KINETIC ANALYSIS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR J. Biol. Chem., November 2, 2001; 276(45): 42191 - 42195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Schroeder, A. M. Gallegos, B. P. Atshaves, S. M. Storey, A. L. McIntosh, A. D. Petrescu, H. Huang, O. Starodub, H. Chao, H. Yang, et al. Recent Advances in Membrane Microdomains: Rafts, Caveolae, and Intracellular Cholesterol Trafficking Experimental Biology and Medicine, November 1, 2001; 226(10): 873 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, Z.-x. Yao, B. Degenhardt, G. Teper, and V. Papadopoulos Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide PNAS, January 23, 2001; (2001) 31461598. [Abstract] [Full Text]
|
|
|
|
|
|
J. E. Baenziger, M.-L. Morris, T. E. Darsaut, and S. E. Ryan Effect of Membrane Lipid Composition on the Conformational Equilibria of the Nicotinic Acetylcholine Receptor J. Biol. Chem., January 14, 2000; 275(2): 777 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vailati, W. Hanke, A. Bejan, B. Barabino, R. Longhi, B. Balestra, M. Moretti, F. Clementi, and C. Gotti Functional alpha 6-Containing Nicotinic Receptors Are Present in Chick Retina Mol. Pharmacol., July 1, 1999; 56(1): 11 - 19. [Abstract] [Full Text]
|
|
|
|
|
|
M. P. Blanton, Y. Xie, L. J. Dangott, and Jonathan. B. Cohen The Steroid Promegestone Is a Noncompetitive Antagonist of the Torpedo Nicotinic Acetylcholine Receptor that Interacts with the Lipid-Protein Interface Mol. Pharmacol., February 1, 1999; 55(2): 269 - 278. [Abstract] [Full Text]
|
|
|
|
|
|
S. Parpal, M. Karlsson, H. Thorn, and P. Stralfors Cholesterol Depletion Disrupts Caveolae and Insulin Receptor Signaling for Metabolic Control via Insulin Receptor Substrate-1, but Not for Mitogen-activated Protein Kinase Control J. Biol. Chem., March 23, 2001; 276(13): 9670 - 9678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Antollini and F. J. Barrantes Unique Effects of Different Fatty Acid Species on the Physical Properties of the Torpedo Acetylcholine Receptor Membrane J. Biol. Chem., January 4, 2002; 277(2): 1249 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, Z.-x. Yao, B. Degenhardt, G. Teper, and V. Papadopoulos Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide PNAS, January 30, 2001; 98(3): 1267 - 1272. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
